CA2288759A1 - Cox-2 selective carprofen for treating pain and inflammation in dogs - Google Patents
Cox-2 selective carprofen for treating pain and inflammation in dogs Download PDFInfo
- Publication number
- CA2288759A1 CA2288759A1 CA002288759A CA2288759A CA2288759A1 CA 2288759 A1 CA2288759 A1 CA 2288759A1 CA 002288759 A CA002288759 A CA 002288759A CA 2288759 A CA2288759 A CA 2288759A CA 2288759 A1 CA2288759 A1 CA 2288759A1
- Authority
- CA
- Canada
- Prior art keywords
- cox
- carprofen
- inflammatory
- activity
- inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4563597P | 1997-05-05 | 1997-05-05 | |
| US60/045635 | 1997-05-05 | ||
| PCT/IB1998/000662 WO1998050033A1 (en) | 1997-05-05 | 1998-05-01 | Cox-2 selective carprofen for treating pain and inflammation in dogs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2288759A1 true CA2288759A1 (en) | 1998-11-12 |
Family
ID=21939053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002288759A Abandoned CA2288759A1 (en) | 1997-05-05 | 1998-05-01 | Cox-2 selective carprofen for treating pain and inflammation in dogs |
Country Status (32)
| Country | Link |
|---|---|
| EP (1) | EP0988034A1 (ko) |
| JP (1) | JP2000513020A (ko) |
| KR (2) | KR20010012300A (ko) |
| CN (1) | CN1255059A (ko) |
| AP (1) | AP9801234A0 (ko) |
| AR (2) | AR011726A1 (ko) |
| AU (1) | AU6932198A (ko) |
| BG (1) | BG103852A (ko) |
| BR (1) | BR9808720A (ko) |
| CA (1) | CA2288759A1 (ko) |
| DZ (1) | DZ2479A1 (ko) |
| EA (1) | EA003696B1 (ko) |
| GT (1) | GT199800063A (ko) |
| HR (1) | HRP980244A2 (ko) |
| HU (1) | HUP0001286A3 (ko) |
| ID (1) | ID21311A (ko) |
| IL (1) | IL132570A0 (ko) |
| IS (1) | IS5220A (ko) |
| MA (1) | MA26491A1 (ko) |
| NO (1) | NO995389L (ko) |
| NZ (1) | NZ500183A (ko) |
| OA (1) | OA11213A (ko) |
| PA (1) | PA8450601A1 (ko) |
| PE (1) | PE72599A1 (ko) |
| PL (1) | PL337003A1 (ko) |
| SK (1) | SK148199A3 (ko) |
| TN (1) | TNSN98059A1 (ko) |
| TW (1) | TW590773B (ko) |
| UY (1) | UY24989A1 (ko) |
| WO (1) | WO1998050033A1 (ko) |
| YU (1) | YU55899A (ko) |
| ZA (1) | ZA983722B (ko) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6245797B1 (en) | 1997-10-22 | 2001-06-12 | Merck & Co., Inc. | Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease |
| AU2003204888B2 (en) * | 1998-05-22 | 2005-07-28 | Pfizer Products Inc. | Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives |
| US6506785B2 (en) * | 1998-05-22 | 2003-01-14 | Pfizer, Inc. | Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives |
| EP1123091A1 (en) * | 1998-10-23 | 2001-08-16 | Merck Frosst Canada & Co. | Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use |
| EP1637137A3 (en) * | 1999-03-10 | 2006-07-05 | G.D. Searle LLC | Method and composition for administering a cyclooxygenase-2 inhibitor to animals |
| AU1592901A (en) * | 1999-11-11 | 2001-06-06 | Eli Lilly And Company | Oncolytic combinations for the treatment of cancer |
| AU2001259974A1 (en) * | 2000-05-15 | 2001-11-26 | Merck Frosst Canada & Co | Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor |
| EA200802070A1 (ru) | 2000-06-13 | 2009-06-30 | Вайет | Болеутоляющее и противовоспалительные составы, содержащие ингибиторы циклооксигеназы-2 |
| DE10032132A1 (de) * | 2000-07-01 | 2002-01-17 | Lohmann Therapie Syst Lts | Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung |
| WO2002012549A1 (en) | 2000-08-07 | 2002-02-14 | Vanderbilt University | Compositions and methods for detecting and quantifying cox-2 activity and 2-arachidonylglycerol metabolites |
| AU2002354901A1 (en) * | 2001-07-16 | 2003-03-03 | Edward Hogestatt | Compounds with analgesic, antipyretic and/or anti-inflammatory activity |
| ATE342722T1 (de) | 2003-05-07 | 2006-11-15 | Osteologix As | Behandlung von knorpel/knochen-erkrankungen mit wasserlöslichen strontiumsalzen |
| KR100780983B1 (ko) * | 2003-07-31 | 2007-11-30 | 파마시아 앤드 업존 캄파니 엘엘씨 | 소염제의 분산성 제제 |
| EP1940380A2 (en) * | 2005-05-20 | 2008-07-09 | Pfizer Limited | Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-2 delta-ligands |
| US9114071B2 (en) | 2007-04-04 | 2015-08-25 | Sigmoid Pharma Limited | Oral pharmaceutical composition |
| JP2010527285A (ja) | 2007-04-26 | 2010-08-12 | シグモイド・ファーマ・リミテッド | 複数のミニカプセルの製造 |
| ES2649112T3 (es) | 2009-05-18 | 2018-01-10 | Sigmoid Pharma Limited | Composición que comprende gotas de aceite |
| WO2011018504A2 (en) | 2009-08-12 | 2011-02-17 | Sigmoid Pharma Limited | Immunomodulatory compositions comprising a polymer matrix and an oil phase |
| GB201020032D0 (en) | 2010-11-25 | 2011-01-12 | Sigmoid Pharma Ltd | Composition |
| GB201212010D0 (en) | 2012-07-05 | 2012-08-22 | Sigmoid Pharma Ltd | Formulations |
| GB201319791D0 (en) | 2013-11-08 | 2013-12-25 | Sigmoid Pharma Ltd | Formulations |
| WO2015134792A1 (en) | 2014-03-06 | 2015-09-11 | Aratana Therapeutics, Inc. | Compositions of grapiprant and methods for using the same |
| BR112017009510A2 (pt) | 2014-11-07 | 2017-12-19 | Sigmoid Pharma Ltd | composições compreendendo ciclosporina |
| CN107106536A (zh) * | 2015-01-09 | 2017-08-29 | 美洲豹动物健康公司 | 治疗伴侣动物的腹泻的方法 |
| US20230174485A1 (en) * | 2020-03-25 | 2023-06-08 | Sri International | Lipoxygenase inhibitors |
| US11116737B1 (en) | 2020-04-10 | 2021-09-14 | University Of Georgia Research Foundation, Inc. | Methods of using probenecid for treatment of coronavirus infections |
| KR102404883B1 (ko) | 2020-11-30 | 2022-06-07 | (주)이노보테라퓨틱스 | 벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3896145A (en) * | 1972-07-24 | 1975-07-22 | Hoffmann La Roche | Carbazoles |
| CA1319886C (en) * | 1987-02-03 | 1993-07-06 | Alberto Ferro | Mixed micelle solutions |
-
1998
- 1998-03-02 DZ DZ980089A patent/DZ2479A1/xx active
- 1998-04-30 TW TW087106689A patent/TW590773B/zh not_active IP Right Cessation
- 1998-05-01 CA CA002288759A patent/CA2288759A1/en not_active Abandoned
- 1998-05-01 NZ NZ500183A patent/NZ500183A/en unknown
- 1998-05-01 PL PL98337003A patent/PL337003A1/xx unknown
- 1998-05-01 WO PCT/IB1998/000662 patent/WO1998050033A1/en not_active Application Discontinuation
- 1998-05-01 HU HU0001286A patent/HUP0001286A3/hu unknown
- 1998-05-01 IL IL13257098A patent/IL132570A0/xx unknown
- 1998-05-01 EP EP98915041A patent/EP0988034A1/en not_active Withdrawn
- 1998-05-01 KR KR1019997010252A patent/KR20010012300A/ko not_active Application Discontinuation
- 1998-05-01 BR BR9808720-7A patent/BR9808720A/pt not_active IP Right Cessation
- 1998-05-01 JP JP10547869A patent/JP2000513020A/ja active Pending
- 1998-05-01 CN CN98804845A patent/CN1255059A/zh active Pending
- 1998-05-01 AU AU69321/98A patent/AU6932198A/en not_active Abandoned
- 1998-05-01 KR KR10-2003-7005258A patent/KR20040004406A/ko not_active Application Discontinuation
- 1998-05-01 ID IDP980651A patent/ID21311A/id unknown
- 1998-05-01 EA EA199900895A patent/EA003696B1/ru not_active IP Right Cessation
- 1998-05-01 SK SK1481-99A patent/SK148199A3/sk unknown
- 1998-05-01 YU YU55899A patent/YU55899A/sh unknown
- 1998-05-04 TN TNTNSN98059A patent/TNSN98059A1/fr unknown
- 1998-05-04 PE PE1998000335A patent/PE72599A1/es not_active Application Discontinuation
- 1998-05-04 ZA ZA9803722A patent/ZA983722B/xx unknown
- 1998-05-04 MA MA25059A patent/MA26491A1/fr unknown
- 1998-05-04 UY UY24989A patent/UY24989A1/es not_active Application Discontinuation
- 1998-05-04 AP APAP/P/1998/001234A patent/AP9801234A0/en unknown
- 1998-05-04 GT GT199800063A patent/GT199800063A/es unknown
- 1998-05-05 HR HR60/045,635A patent/HRP980244A2/hr not_active Application Discontinuation
- 1998-05-05 AR ARP980102089A patent/AR011726A1/es unknown
- 1998-05-05 PA PA19988450601A patent/PA8450601A1/es unknown
-
1999
- 1999-10-19 IS IS5220A patent/IS5220A/is unknown
- 1999-11-02 OA OA9900242A patent/OA11213A/en unknown
- 1999-11-03 BG BG103852A patent/BG103852A/xx unknown
- 1999-11-04 NO NO995389A patent/NO995389L/no not_active Application Discontinuation
-
2003
- 2003-04-09 AR ARP030101251A patent/AR039628A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2288759A1 (en) | Cox-2 selective carprofen for treating pain and inflammation in dogs | |
| Moreno-Sánchez et al. | Inhibition and uncoupling of oxidative phosphorylation by nonsteroidal anti-inflammatory drugs: study in mitochondria, submitochondrial particles, cells, and whole heart | |
| Duggan | Esaxerenone: first global approval | |
| US8389563B2 (en) | C-substituted diindolylmethane compositions and methods for the treatment of multiple cancers | |
| US6399647B2 (en) | Amide derivatives for antiangiogenic and/or antitumorigenic use | |
| ES2544482T3 (es) | Compuesto rexinoide que tiene un grupo alcoxi | |
| TWI496572B (zh) | 用於治療過度增生性疾病之新穎組成物及方法 | |
| US20030212123A1 (en) | COX-2 selective carprofen for treating pain and inflammation in dogs | |
| JP2006523698A (ja) | Ｐｐａｒ変調薬としての（３−｛３−（２，４−ビス−トリフルオロメチル−ベンジル）−（５−エチル−ピリミジン−２−イル）−アミノ−プロポキシ｝−フェニル）−酢酸および関連化合物、ならびに代謝性障害の処置方法 | |
| JP2001514655A (ja) | アルツハイマー病予防へのｒ−ｎｓａｉｄ’ｓの利用 | |
| JP2003526663A (ja) | Ｃｏｍｔ阻害剤の鎮痛剤としての用途 | |
| AU773615B2 (en) | COX-2 selective carprofen for treating pain and inflammation in dogs | |
| NZ516914A (en) | Compositions containing COX-2 selective carprofen and derivatives thereof for treating pain and inflammation in dogs | |
| JP2000086629A (ja) | 新規な酸化窒素放出化合物 | |
| Estato et al. | Effects of centrally acting antihypertensive drugs on the microcirculation of spontaneously hypertensive rats | |
| CZ9903896A3 (cs) | Léčivo, farmaceutický přípravek a souprava pro léčení nebo prevenci bolesti a zánětlivých procesů | |
| Black | Selective cyclooxygenase-2 inhibitors | |
| JP2004511436A (ja) | 失禁用医薬 | |
| US20150065486A1 (en) | Methods for treating polycystic kidney disease | |
| JP2007529510A (ja) | 細胞接着を抑制するメチマゾール誘導体及び互変異性環状チオン | |
| JP2007504164A (ja) | ＰＰＡＲ−γ経路およびＨＥＲ−キナーゼ軸の調節に基づく癌および他の生理学的状態の処置のための組成物および方法 | |
| Kendall et al. | Pharmacology of Analgesics | |
| Maboudian‐Esfahani et al. | Pharmacokinetics of ethopropazine in the rat after oral and intravenous administration | |
| Amir et al. | COX-2-inhibitor—a new class of analgesic and anti-inflammatory drugs | |
| CN101087768A (zh) | 血小板生成素活性调节化合物和方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |